CAC40: a fairly stable start to the session

(CercleFinance.com) - Down seven points to 7512, futures on the CAC40 are foreshadowing a hesitant start to the session this Friday, when investors' attention could be focused on the numerous corporate publications released since last night.


Sanofi has just reported a 17.6% increase in business EPS at constant exchange rates for the third quarter of 2024, with sales growth of almost 16% 'reflecting the dynamic of the product portfolio'.

"This performance was underpinned by a favorable sequence of sales of influenza vaccines and Beyfortus, 67% growth in our new medicines, as well as volume-driven growth in Dupixent", explains CEO Paul Hudson.

Claiming a good performance to end September, Safran raises its ROC target for 2024, despite a lowered sales target in the wake of its original equipment deliveries forecasts for short- and medium-haul aircraft.

Among the day's other quarterly publications in Paris, operators will also be able to react to those of Vinci, Accor, Valéo and Unibail-Rodamco-Westfield last night, as well as Groupe Seb, Bolloré, Nexity, Wendel and Rémy Cointreau.

In terms of the day's data, operators will be paying particular attention to the Ifo business climate index in Germany, in the morning, followed by the number of job seekers in France for the third quarter, at midday.

On the other side of the Atlantic, last month's US durable goods orders will be released in the afternoon, followed by the University of Michigan's final consumer confidence index for October.

Copyright (c) 2024 CercleFinance.com. All rights reserved.